Laboratory Historical Financial Ratios

LH Stock

USD 242.15 3.42 1.43%

Laboratory is lately reporting on over 112 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 67.82, Book Value Per Share of 95.12 or Free Cash Flow Yield of 0.0591 will help investors to properly organize and evaluate Laboratory financial condition quickly.

Quick Ratio Current Ratio

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

About Laboratory Financial Ratios Analysis

LaboratoryFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Laboratory investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Laboratory financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Laboratory history.

Laboratory Financial Ratios Chart

As of now, Laboratory's Free Cash Flow Yield is decreasing as compared to previous years. The Laboratory's current Operating Cash Flow Per Share is estimated to increase to 16.01, while Price To Sales Ratio is projected to decrease to 1.57.

Price To Sales Ratio Ptb Ratio Days Sales Outstanding Invested Capital Interest Coverage Net Income Per E B T

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Laboratory stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Laboratory sales, a figure that is much harder to manipulate than other Laboratory of multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Invested Capital

Invested capital represents the total cash investment that shareholders and debt holders have contributed to Laboratory of. There are two different methods for calculating Laboratory invested capital: operating approach and financing approach. Understanding Laboratory invested capital allows investors to calculate measures of performance such as return on invested capital or return on capital employed.

Most ratios from Laboratory's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Laboratory current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

	2023	2024 (projected)
Dividend Yield	0.0128	0.0122
Price To Sales Ratio	1.63	1.57

Dividend Yield Price To Sales Ratio

Laboratory fundamentals Correlations

	Price To Sales Ratio	Dividend Yield	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Payout Ratio	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe
Price To Sales Ratio		0.79	0.68	0.26	-0.11	-0.58	-0.1	0.77	0.68	0.93	-0.09	0.48	-0.24	-0.14	0.18	0.68	0.77	-0.05	0.76	0.24	0.88	0.35	0.68	-0.56	0.17	0.03
Dividend Yield	0.79		0.45	0.08	-0.45	-0.5	-0.46	0.93	0.45	0.79	-0.42	0.65	0.01	-0.34	-0.04	0.64	0.89	-0.35	0.59	0.27	0.94	0.32	0.48	-0.52	-0.22	0.18
Ptb Ratio	0.68	0.45		-0.2	-0.44	-0.35	-0.35	0.59	1.0	0.53	-0.34	0.31	-0.05	-0.43	-0.07	0.54	0.51	-0.16	0.48	0.19	0.58	0.33	0.53	-0.5	0.28	0.19
Days Sales Outstanding	0.26	0.08	-0.2		0.57	-0.09	0.49	-0.04	-0.2	0.3	0.47	-0.07	-0.09	0.38	0.12	0.31	0.08	0.53	0.18	-0.08	0.18	0.11	0.23	-0.3	0.21	-0.31
Book Value Per Share	-0.11	-0.45	-0.44	0.57		0.09	0.88	-0.45	-0.44	-0.17	0.81	-0.42	-0.31	0.64	0.34	-0.08	-0.33	0.58	-0.07	-0.11	-0.31	0.01	0.02	0.04	0.36	-0.47
Free Cash Flow Yield	-0.58	-0.5	-0.35	-0.09	0.09		0.41	-0.57	-0.35	-0.7	0.5	0.25	0.04	0.62	-0.07	-0.11	-0.73	0.39	-0.96	0.56	-0.69	-0.87	-0.93	0.02	-0.55	0.61
Operating Cash Flow Per Share	-0.1	-0.46	-0.35	0.49	0.88	0.41		-0.49	-0.35	-0.23	0.99	-0.1	-0.34	0.9	0.33	0.06	-0.47	0.78	-0.33	0.28	-0.41	-0.37	-0.29	-0.09	0.06	-0.05
Capex To Depreciation	0.77	0.93	0.59	-0.04	-0.45	-0.57	-0.49		0.59	0.72	-0.48	0.55	-0.06	-0.43	0.01	0.63	0.96	-0.38	0.63	0.22	0.93	0.49	0.59	-0.52	-0.08	0.15
Pb Ratio	0.68	0.45	1.0	-0.2	-0.44	-0.35	-0.35	0.59		0.53	-0.34	0.31	-0.05	-0.43	-0.07	0.54	0.51	-0.16	0.48	0.19	0.58	0.33	0.53	-0.5	0.28	0.19
Ev To Sales	0.93	0.79	0.53	0.3	-0.17	-0.7	-0.23	0.72	0.53		-0.22	0.37	-0.08	-0.26	0.06	0.53	0.77	-0.19	0.82	0.0	0.87	0.42	0.71	-0.39	0.17	-0.1
Free Cash Flow Per Share	-0.09	-0.42	-0.34	0.47	0.81	0.5	0.99	-0.48	-0.34	-0.22		0.03	-0.33	0.94	0.31	0.1	-0.49	0.81	-0.4	0.4	-0.41	-0.49	-0.38	-0.13	-0.06	0.08
Roic	0.48	0.65	0.31	-0.07	-0.42	0.25	-0.1	0.55	0.31	0.37	0.03		-0.08	0.24	0.0	0.59	0.36	-0.02	-0.09	0.84	0.43	-0.44	-0.24	-0.52	-0.74	0.83
Inventory Turnover	-0.24	0.01	-0.05	-0.09	-0.31	0.04	-0.34	-0.06	-0.05	-0.08	-0.33	-0.08		-0.26	-0.98	0.15	0.01	-0.41	-0.19	-0.33	-0.07	0.13	-0.08	-0.23	-0.15	-0.03
Net Income Per Share	-0.14	-0.34	-0.43	0.38	0.64	0.62	0.9	-0.43	-0.43	-0.26	0.94	0.24	-0.26		0.25	0.1	-0.48	0.72	-0.54	0.54	-0.43	-0.65	-0.57	-0.12	-0.37	0.33
Days Of Inventory On Hand	0.18	-0.04	-0.07	0.12	0.34	-0.07	0.33	0.01	-0.07	0.06	0.31	0.0	-0.98	0.25		-0.26	-0.03	0.37	0.22	0.23	0.05	-0.11	0.08	0.34	0.17	-0.05
Payables Turnover	0.68	0.64	0.54	0.31	-0.08	-0.11	0.06	0.63	0.54	0.53	0.1	0.59	0.15	0.1	-0.26		0.56	0.17	0.23	0.48	0.63	0.13	0.3	-0.98	-0.13	0.26
Capex To Revenue	0.77	0.89	0.51	0.08	-0.33	-0.73	-0.47	0.96	0.51	0.77	-0.49	0.36	0.01	-0.48	-0.03	0.56		-0.41	0.76	-0.01	0.94	0.66	0.73	-0.45	0.08	-0.07
Cash Per Share	-0.05	-0.35	-0.16	0.53	0.58	0.39	0.78	-0.38	-0.16	-0.19	0.81	-0.02	-0.41	0.72	0.37	0.17	-0.41		-0.28	0.36	-0.32	-0.37	-0.26	-0.2	0.05	0.06
Pocfratio	0.76	0.59	0.48	0.18	-0.07	-0.96	-0.33	0.63	0.48	0.82	-0.4	-0.09	-0.19	-0.54	0.22	0.23	0.76	-0.28		-0.38	0.79	0.77	0.95	-0.12	0.55	-0.51
Interest Coverage	0.24	0.27	0.19	-0.08	-0.11	0.56	0.28	0.22	0.19	0.0	0.4	0.84	-0.33	0.54	0.23	0.48	-0.01	0.36	-0.38		0.07	-0.66	-0.48	-0.46	-0.65	0.82
Payout Ratio	0.88	0.94	0.58	0.18	-0.31	-0.69	-0.41	0.93	0.58	0.87	-0.41	0.43	-0.07	-0.43	0.05	0.63	0.94	-0.32	0.79	0.07		0.55	0.74	-0.51	0.12	-0.07
Capex To Operating Cash Flow	0.35	0.32	0.33	0.11	0.01	-0.87	-0.37	0.49	0.33	0.42	-0.49	-0.44	0.13	-0.65	-0.11	0.13	0.66	-0.37	0.77	-0.66	0.55		0.9	-0.1	0.67	-0.69
Pfcf Ratio	0.68	0.48	0.53	0.23	0.02	-0.93	-0.29	0.59	0.53	0.71	-0.38	-0.24	-0.08	-0.57	0.08	0.3	0.73	-0.26	0.95	-0.48	0.74	0.9		-0.22	0.7	-0.61
Days Payables Outstanding	-0.56	-0.52	-0.5	-0.3	0.04	0.02	-0.09	-0.52	-0.5	-0.39	-0.13	-0.52	-0.23	-0.12	0.34	-0.98	-0.45	-0.2	-0.12	-0.46	-0.51	-0.1	-0.22		0.13	-0.25
Income Quality	0.17	-0.22	0.28	0.21	0.36	-0.55	0.06	-0.08	0.28	0.17	-0.06	-0.74	-0.15	-0.37	0.17	-0.13	0.08	0.05	0.55	-0.65	0.12	0.67	0.7	0.13		-0.81
Roe	0.03	0.18	0.19	-0.31	-0.47	0.61	-0.05	0.15	0.19	-0.1	0.08	0.83	-0.03	0.33	-0.05	0.26	-0.07	0.06	-0.51	0.82	-0.07	-0.69	-0.61	-0.25	-0.81

Click cells to compare fundamentals

Laboratory Account Relationship Matchups

Laboratory fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Ptb Ratio	1.88	1.82	2.54	1.83	2.51	3.28
Days Sales Outstanding	63.98	78.77	67.43	49.0	62.99	67.82
Book Value Per Share	77.29	96.19	106.23	110.83	90.59	95.12
Free Cash Flow Yield	0.0841	0.0734	0.1	0.08	0.0442	0.0591
Operating Cash Flow Per Share	14.76	21.95	32.16	21.47	15.24	16.01
Stock Based Compensation To Revenue	0.00926	0.007991	0.008244	0.007851	0.0106	0.009973
Pb Ratio	1.88	1.82	2.54	1.83	2.51	3.28
Free Cash Flow Per Share	10.67	18.02	27.4	16.18	10.04	10.54
Inventory Turnover	33.93	21.33	26.15	22.29	18.53	31.7
Net Income Per Share	8.41	15.99	24.58	14.04	4.8	3.85
Days Of Inventory On Hand	10.76	17.11	13.96	16.37	19.69	10.43
Payables Turnover	13.13	14.13	16.89	12.31	10.63	16.73
Capex To Revenue	0.0346	0.0273	0.0286	0.0324	0.0373	0.0387
Cash Per Share	3.54	13.57	15.34	4.72	6.16	6.47
Pocfratio	9.85	7.97	8.39	9.42	14.91	12.4
Interest Coverage	5.53	11.79	15.37	9.84	3.64	3.45
Pfcf Ratio	13.62	9.7	9.85	12.5	22.65	23.78
Days Payables Outstanding	27.8	25.84	21.6	29.65	34.34	20.38
Income Quality	1.75	1.37	1.31	1.53	3.49	3.66
Ev To Operating Cash Flow	14.52	10.51	9.96	12.42	18.99	16.63
Pe Ratio	17.27	10.93	10.98	14.41	47.36	49.73
Ev To Free Cash Flow	20.08	12.8	11.69	16.48	28.85	30.29
Earnings Yield	0.0579	0.0915	0.0911	0.0694	0.0211	0.0344
Net Debt To E B I T D A	3.19	1.67	1.14	3.0	4.03	3.39
Current Ratio	1.13	1.66	1.92	1.5	1.17	1.76
Tangible Book Value Per Share	(44.25)	(24.18)	(14.7)	(21.64)	(18.3)	(19.22)
Receivables Turnover	5.71	4.63	5.41	7.45	5.79	5.02
Graham Number	120.97	186.05	242.41	187.12	98.81	103.75
Shareholders Equity Per Share	77.29	96.19	106.23	110.83	90.41	94.93

Currently Active Assets on Macroaxis

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C
MSFT	Microsoft
GM	General Motors

How To Invest In Laboratory

Details

Is Laboratory Stock a good investment?

Details

What is Laboratory's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.05)

Dividend Share

2.88

Earnings Share

5.28

Revenue Per Share

151.028

Quarterly Revenue Growth

0.074

The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Laboratory Historical Financial Ratios

About Laboratory Financial Ratios Analysis

Laboratory Financial Ratios Chart

Price To Sales Ratio

Ptb Ratio

Invested Capital

Laboratory fundamentals Correlations

Laboratory Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Laboratory fundamentals Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Pb Ratio	+ 1.0	Ptb Ratio
Free Cash Flow Per Share	+ 0.99	Operating Cash Flow Per Share
Capex To Revenue	+ 0.96	Capex To Depreciation
Pfcf Ratio	+ 0.95	Pocfratio
Payout Ratio	+ 0.94	Dividend Yield
Net Income Per Share	+ 0.94	Free Cash Flow Per Share

Days Payables Outstanding	- 0.98	Payables Turnover
Days Of Inventory On Hand	- 0.98	Inventory Turnover
Pocfratio	- 0.96	Free Cash Flow Yield
Pfcf Ratio	- 0.93	Free Cash Flow Yield
Capex To Operating Cash Flow	- 0.87	Free Cash Flow Yield
Roe	- 0.81	Income Quality